إعلان شركة دله للخدمات لصحية عن تعيين الرئيس التنفيذي للشركة

Dallah Healthcare Company Announces the Appointment of the Chief Executive Officer 4004 DALLAH HEALTH 0.57 % 1448/04/19     30/09/2026 08:11:47 Introduction With reference to the announcement of Dallah Healthcare Company (the “Company”) published on the Saudi Exchange (Tadawul) website on 7 Rabi’ Al-Awwal 1448H, corresponding to 20 August 2026G, regarding the appointment of an Acting Chief Executive Officer of the Company, the Company announces the resolution of its Board of Directors dated 18 Rabi’ Al-Thani 1448H, corresponding to 29 September 2026G, to appoint Eng. Muteab bin Abdullah Altukeas as Chief Executive Officer of the Company, effective from 19 Rabi’ Al-Thani 1448H, corresponding to 30 September 2026G. Appointment Type Appointment Name of the Appointed Person Eng. Muteab bin Abdullah Altukeas Date of Board Resolution 2026-09-29 Corresponding to 1448-04-18 Date Work Commencement 2026-09-30 Corresponding to 1448-04-19 Brief Resume Eng. Muteab bin Abdullah Altukeas holds a Master’s degree in Project Management from Heriot-Watt University in the United Kingdom and a Bachelor’s degree in Civil Engineering from King Saud University. He has more than 15 years of professional and leadership experience in strategy, project management, and mergers and acquisitions. He has served as Chief Strategy Officer at Dallah Healthcare Company since 2022 and previously served as General Manager of Strategy and the Project Management Office at the Company from 2017 to 2022. He also has experience serving on boards and committees, as well as overseeing strategic projects and investments. He holds a number of professional certifications and has completed several executive and specialized programs, including the Mergers and Acquisitions Program at Harvard University, as well as executive and finance programs at London Business School. The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. Share